Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Acute Myocardial Infarction Study in Northeastern China

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04451967
Recruitment Status : Recruiting
First Posted : June 30, 2020
Last Update Posted : June 30, 2020
Sponsor:
Collaborators:
Yanbian University Hospital
Dunhua City Hospital in Jilin Province
Liaoyuan City Central Hospital
Dongliao People's Hospital
Songyuan Central Hospital
Changling People's Hospital
Siping Central Hospital
The First People's Hospital of Manchu Autonomous County
Changchun Center Hospital
Nongan People's Hospital
Beihua University
Jilin Hospital of Integrated Traditional Chinese and Western Medicine
Panshi City Hospital
Tonghua Central Hospital
Baishan Central Hospital
Jingyu People's Hospital
Meihekou Central Hospital
Baicheng Central Hospital
Tongyu First Hospital
Information provided by (Responsible Party):
Second Hospital of Jilin University

Brief Summary:
This is a real-world prospective cohort study aiming to generate knowledge about the characteristics, treatments, and outcomes of hospitalized AMI patients in Jilin Province. The study includes hospitalizations diagnosed of AMI, including ST segment-elevation myocardial infarction (STEMI) and non-ST-segment-elevation myocardial infarction (NSTEMI).

Condition or disease Intervention/treatment
Acute Myocardial Infarction Procedure: thrombolysis

Layout table for study information
Study Type : Observational
Estimated Enrollment : 3159 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: the Acute Myocardial Infarction Study in Northeastern China
Actual Study Start Date : September 9, 2019
Estimated Primary Completion Date : September 9, 2020
Estimated Study Completion Date : September 9, 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Attack

Group/Cohort Intervention/treatment
Transfer after thrombolysis Procedure: thrombolysis
transfer after thrombolysis for STEMI patients within 6h since onset
Other Name: DAPT

Transfer after DAPT
Direct transfer



Primary Outcome Measures :
  1. all-cause death [ Time Frame: 2 years post discharge ]
    all-cause death


Secondary Outcome Measures :
  1. major adverse cardiac events (MACE) [ Time Frame: 2 years post discharge ]
    recurrent angina, non-fatal myocardial infarction, cardiac failure, malignant arrhythmia, and death from cardiovascular causes



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Eligible patients must be admitted within 7 days of acute myocardial ischemic symptoms with a primary clinical diagnosis of AMI, including ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI). Final inclusion criteria must meet Fourth Universal Definition for Myocardial Infarction (2018)
Criteria

Inclusion Criteria:

  • patients admitted within 7 days of acute myocardial ischemic symptoms with a primary clinical diagnosis of AMI, meet Fourth Universal Definition for Myocardial Infarction (2018)

Exclusion Criteria:

  • Types 4a and type 5 AMI

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04451967


Contacts
Layout table for location contacts
Contact: Tianyi Li, Ph.D +8615843024731 litianyi@jlu.edu.cn

Locations
Layout table for location information
China, Jilin
The second hospital of Jilin university Recruiting
Changchun, Jilin, China, 130041
Contact: He Wang, Doctor    043188796625    wanghe221@163.com   
Sponsors and Collaborators
Second Hospital of Jilin University
Yanbian University Hospital
Dunhua City Hospital in Jilin Province
Liaoyuan City Central Hospital
Dongliao People's Hospital
Songyuan Central Hospital
Changling People's Hospital
Siping Central Hospital
The First People's Hospital of Manchu Autonomous County
Changchun Center Hospital
Nongan People's Hospital
Beihua University
Jilin Hospital of Integrated Traditional Chinese and Western Medicine
Panshi City Hospital
Tonghua Central Hospital
Baishan Central Hospital
Jingyu People's Hospital
Meihekou Central Hospital
Baicheng Central Hospital
Tongyu First Hospital
Investigators
Layout table for investigator information
Principal Investigator: Bin Liu, Ph.D Second Hospital of Jilin University
Layout table for additonal information
Responsible Party: Second Hospital of Jilin University
ClinicalTrials.gov Identifier: NCT04451967    
Other Study ID Numbers: SecondJilinU-AMINoC
First Posted: June 30, 2020    Key Record Dates
Last Update Posted: June 30, 2020
Last Verified: June 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Myocardial Infarction
Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases